| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/04/2003 | US20030166835 Dehydroalanine-containing lantibiotic |
| 09/04/2003 | US20030166834 A polypeptide containing at least 30 consecutive amino acids present within amino acids 1 to 130 of a cynomolgus macaque MCH1R sequence, and the polypeptide exhibits MCH1R ligand binding activity |
| 09/04/2003 | US20030166833 Growth factor modified protein matrices for tissue engineering |
| 09/04/2003 | US20030166832 Methods and compositions for impairing multiplication of HIV-1 |
| 09/04/2003 | US20030166603 Using a p53- expressing viral vector as anticarcinogenic agents |
| 09/04/2003 | US20030166600 An isolated polynucleotide encoding the proteins, receptor binding assay, drug screening, culturing, kits for analyzing; treating obesity, cancer, diabetes, osteoporosis, anxiety, depression, hypertension, migraine, schizophrenia |
| 09/04/2003 | US20030166599 Uses of tgap7 for the modulation of leucocyte activation |
| 09/04/2003 | US20030166593 Non-viral vesicle vector for cardiac specific gene delivery |
| 09/04/2003 | US20030166591 Testosterone-repressed prostate message-2 (TRPM-2); gene expression inhibition; increased antitumor activity |
| 09/04/2003 | US20030166590 Microsomal triglyceride transfer protein |
| 09/04/2003 | US20030166586 C/EBP beta isoforms and methods of use in cell regulation and anti-tumorigenesis |
| 09/04/2003 | US20030166571 Comprises hexapeptides as agonists/antagonists when exposed to human ORL-1 (orphan) receptors; anxiolytics, diuretics, anticancer agents |
| 09/04/2003 | US20030166570 Peptide and its use in the treatment of hyperpigmentation conditions |
| 09/04/2003 | US20030166569 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 09/04/2003 | US20030166567 Anti-aging and wound healing compounds |
| 09/04/2003 | US20030166565 CD antigens; for regulating inflammation; nuclear magnetic resonance; drug screening |
| 09/04/2003 | US20030166563 Vpr proteins; lentiviral pol gene expression; human and simian immunodeficiency virus (HIV/SIV) vectors |
| 09/04/2003 | US20030166561 Such as preptin which is secreted by the pancreatic islet beta-cells for stimulating insulin secretion; immunoassay; kits |
| 09/04/2003 | US20030166560 Snail/mollusc polypeptides; anticonvulsant drug screening |
| 09/04/2003 | US20030166559 Comprises tumor necrosis factor antagonist activity for treatment of autoimmune conditions |
| 09/04/2003 | US20030166558 Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha-synuclein, or polyglutamine repeats for induction of an immune response thereto |
| 09/04/2003 | US20030166556 Immunoregulator |
| 09/04/2003 | US20030166552 For removing viruses from samples (for protection against acquired immunodeficiency syndrome); contraceptives |
| 09/04/2003 | US20030166551 For inhibiting expression of adhesion molecules in vascular endothelial cells comprising adipose tissue-specific secretory factor |
| 09/04/2003 | US20030166548 Synthetic milittin and related peptides derived from the sequence of human phospholipase A2-activating protein (PLAP), free from the contaminating phospholipase A2 (PLA2) and/or present when the peptides are purified from natural sources, |
| 09/04/2003 | US20030166547 Inducing angiogenesis in a tissue in need of angiogenesis, comprising providing the tissue in need of angiogenesis with an angiogenically effective amount of a recombinant c-fos induced growth factor/vascular endothelial growth factor D |
| 09/04/2003 | US20030166545 Compounds and use thereof to modify transport across cell membranes |
| 09/04/2003 | US20030166543 Functional antagonists of hedgehog activity |
| 09/04/2003 | US20030166541 Novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. |
| 09/04/2003 | US20030166540 Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY30 |
| 09/04/2003 | US20030166538 Isolated inflammation-related gene, the protein molecule encoded by the gene, and the use of the gene in diagnosis and treatment of inflammatory conditions. |
| 09/04/2003 | US20030166536 Expression product of DNA encoding human or hybrid human/ mammalian factor VIII, said DNA comprising DNA encoding a modified A2 domain, the DNA having one or more nucleotide substitutions resulting in a coding change at one or more of |
| 09/04/2003 | US20030166533 Genes for male accessory gland proteins in Drosophila melanogaster |
| 09/04/2003 | US20030166532 Annexin V, is used to prevent thrombosis without increasing hemorrhage. Annexin binds to phosphatidylserine on the outer surface of cell membranes, thereby preventing binding of the prothrombinase complex necessary for thrombus formation. |
| 09/04/2003 | US20030166530 Conjugate heat shock protein-binding peptides |
| 09/04/2003 | US20030166529 Polypeptides and their uses |
| 09/04/2003 | US20030166528 Antifungal compound |
| 09/04/2003 | US20030166527 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs. |
| 09/04/2003 | US20030166526 Novel gene (designated 158P1H4) and its encoded protein are described. While 158P1H4 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed in multiple cancers including set forth in Table 1. Consequently, 158P1H4 |
| 09/04/2003 | US20030166525 FSH Formulation |
| 09/04/2003 | US20030166524 Therapeutic uses of IL-1 receptor antagonist |
| 09/04/2003 | US20030166523 Activating only the vascular endothelial growth factor receptor-3 has been created. The method comprises administration of a composition comprising a polypeptide to an animal wherein the composition has the ability to stimulate |
| 09/04/2003 | US20030166522 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/04/2003 | US20030166521 Inhibition of thrombosis by treatment with P-selectin antagonists |
| 09/04/2003 | US20030166519 Agents that modulate growth regulation and cell differentiation. More particularly, the present invention relates to novel OKL38 polypeptides that modulate growth regulation and differentiation of mammary epithelial cells |
| 09/04/2003 | US20030166505 Neo-tryptophan |
| 09/04/2003 | US20030166504 Therapeutic compositions and methods for treating viral infection |
| 09/04/2003 | US20030166502 Methods for selectively regulating survival and proliferation in a T cell by modulating the activity of certain amino acid motifs in the CD28 protein. |
| 09/04/2003 | US20030166501 Mucin-related tumor marker |
| 09/04/2003 | US20030166300 Growth-related inflammatory and immune response protein |
| 09/04/2003 | US20030166289 Compositions and methods for regulating bacterial pathogenesis |
| 09/04/2003 | US20030166288 Altering Ku80 levels in plants; recobinant expression cassettes |
| 09/04/2003 | US20030166286 Chimeric adenoviral fiber protein and methods of using same |
| 09/04/2003 | US20030166285 Methods and compositions for genetically modifying primate bone marrow cells |
| 09/04/2003 | US20030166284 Encoding hepatitis B virus surface antigen, treating hepatic diseases; inverted terminal repeats has the native D-sequences modified, some nucleotides are deleted or replaced; genetic engineering |
| 09/04/2003 | US20030166281 Genetic transcription, cells comprising regulatory sequence, a reporter gene to express a signal peptide, protein biosynthesis; reducing neutrophils, expression of human growth hormone |
| 09/04/2003 | US20030166277 Targeted vaccine delivery systems |
| 09/04/2003 | US20030166275 Preparation of erythropoietin by endogenous gene activation |
| 09/04/2003 | US20030166268 An isolated polynucleotide encodes a polypeptide antibodies and antiidiotypic antibodies; treating cytokine-induced inflammation, inhibiting viral proliferation; antiproliferative agents, viricides |
| 09/04/2003 | US20030166258 Saccharomyces cerevisiae yeast strain with functional expression of a glut transporter |
| 09/04/2003 | US20030166254 Moving promoter distal gene toward a wild-type 3' gene; gene mapping, genetic engineering; an attenuated virus useful for a vaccine |
| 09/04/2003 | US20030166252 Paramyxovirus-derived RNP |
| 09/04/2003 | US20030166247 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures |
| 09/04/2003 | US20030166245 For preparing reagents for use in detecting molecules which affect formation of actin cytoskeleton; drug screening |
| 09/04/2003 | US20030166243 Regulation of target protein activity through modifier proteins |
| 09/04/2003 | US20030166240 DNA & protein binding miniature proteins |
| 09/04/2003 | US20030166239 Bone morphogenic proteins; for regulating bone homeostasis, adiposity, and calcification of atherosclerotic plaques |
| 09/04/2003 | US20030166238 Recombinant toxin fragments |
| 09/04/2003 | US20030166232 PARG, a GTPase activating protein which interacts with PTPL1 |
| 09/04/2003 | US20030166231 Novel human RNA-binding protein |
| 09/04/2003 | US20030166230 Retinoblastoma tumor suppressor genes/proteins; animal models; competitive binding |
| 09/04/2003 | US20030166229 Human POSH-like protein 1 |
| 09/04/2003 | US20030166227 Comprises polypeptides having exonuclease domains in plants; homologous recombination |
| 09/04/2003 | US20030166203 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 09/04/2003 | US20030166197 Isolated polynucleotide of given sequence encoding a EIN6 protein; transforming cell to desired phenotype |
| 09/04/2003 | US20030166196 Fusion proteins and polynucleotides encoding gelonin sequences |
| 09/04/2003 | US20030166194 Of given sequence; genetic mapping; anticoagulants |
| 09/04/2003 | US20030166193 Suppressors of death domains |
| 09/04/2003 | US20030166192 Nucleic acid encoding a converting enzyme (pseudo-ICE) that has specific binding to pro-caspase or RICK protein and stimulates necrosis factor-kappa B activation; use in modulating apoptosis or inflammation |
| 09/04/2003 | US20030166190 Nucleic acids related to plant retroelements |
| 09/04/2003 | US20030166188 Of given amino acid sequence; use in diagnostics and stimulating release of tumor necrosis factor from blood |
| 09/04/2003 | US20030166186 Method of preventing decrease in the activity of protein due to freezing and use of polypeptide in the production of protein activity decrease preventing agent |
| 09/04/2003 | US20030166183 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 09/04/2003 | US20030166175 Process for clavulanic acid production |
| 09/04/2003 | US20030166173 Nucleotide sequences coding for the glbO gene |
| 09/04/2003 | US20030166171 Genes encoding exopolysaccharide production |
| 09/04/2003 | US20030166168 Variant varicella-zoster viruses and methods of use |
| 09/04/2003 | US20030166167 Adenoviral library assay for E2F regulatory genes and methods and compositions for screening compounds |
| 09/04/2003 | US20030166164 IL-17 like molecules and uses thereof |
| 09/04/2003 | US20030166163 Immunocytokines with modulated selectivity |
| 09/04/2003 | US20030166162 Preparing genetically engineered polypeptides/zymogens for pharmaceutical or food composition |
| 09/04/2003 | US20030166161 Gene that imparts selective proliferative activity |
| 09/04/2003 | US20030166160 Compounds and molecular complexes comprising multiple binding regions directed to transcytotic ligands |
| 09/04/2003 | US20030166159 Novel transcription factor regulating TNF-alpha |
| 09/04/2003 | US20030166158 NTR3, a novel member of the TNF-receptor supergene family |
| 09/04/2003 | US20030166156 Comprises secretin-glucagon-vasoactive intestinal peptide (VIP) for diagnosing and treatment of inflammatory pancreatic disorders |
| 09/04/2003 | US20030166155 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/04/2003 | US20030166154 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 09/04/2003 | US20030166153 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/04/2003 | US20030166152 Methods and materials relating to novel prothrombinase-like polypeptides and polynucleotides |